Paul Richardson, MD: Current Therapies for Multiple Myeloma

December 15, 2015- Interviewed by Steven Greer, MD

Dr. Paul Richardson, Clinical Director of the Multiple Myeloma Center at Harvard’s Dana-Farber Cancer Institute gives an overview of the current standard of care for patients with multiple myeloma

This entry was posted in - Biotech, - Pharma, Harvard, Oncology. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *